Chemomab Therapeutics Ltd.

Healthcare · Biotechnology · Israel

Last price 1.09 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 7.90M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases. Its lead product candidate is nebokitug, a humanized monoclonal antibody that attenuates the basic function of CCL24 as a regulator of major inflammatory and fibrotic pathways, which has completed phase 2 clinical trial for treating primary sclerosing cholangitis, as well as in phase 2 clinical trial to treat systemic sclerosis. The company was founded in 2011 and i...